Anuja Kriplani

432 total citations
33 papers, 222 citations indexed

About

Anuja Kriplani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Anuja Kriplani has authored 33 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Anuja Kriplani's work include Head and Neck Cancer Studies (8 papers), Pain Management and Opioid Use (4 papers) and Cancer Diagnosis and Treatment (4 papers). Anuja Kriplani is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Pain Management and Opioid Use (4 papers) and Cancer Diagnosis and Treatment (4 papers). Anuja Kriplani collaborates with scholars based in United States and India. Anuja Kriplani's co-authors include Lara Dunn, Eric J. Sherman, David G. Pfister, Alan L. Ho, James Fetten, Loren S. Michel, Nora Katabi, Irina Ostrovnaya, Nancy Y. Lee and Ian Ganly and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Anuja Kriplani

28 papers receiving 219 citations

Peers

Anuja Kriplani
R. J. Sanderson United Kingdom
Nobuya Monden Japan
Bernard Lyons Australia
Jamie A. Ku United States
Mateya Trinkaus Canada
Aline Lauda Freitas Chaves Brazil
Laura M. Dooley United States
Caitlin McMullen United States
Jun Yong China
Daniel Moualed United Kingdom
R. J. Sanderson United Kingdom
Anuja Kriplani
Citations per year, relative to Anuja Kriplani Anuja Kriplani (= 1×) peers R. J. Sanderson

Countries citing papers authored by Anuja Kriplani

Since Specialization
Citations

This map shows the geographic impact of Anuja Kriplani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anuja Kriplani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anuja Kriplani more than expected).

Fields of papers citing papers by Anuja Kriplani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anuja Kriplani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anuja Kriplani. The network helps show where Anuja Kriplani may publish in the future.

Co-authorship network of co-authors of Anuja Kriplani

This figure shows the co-authorship network connecting the top 25 collaborators of Anuja Kriplani. A scholar is included among the top collaborators of Anuja Kriplani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anuja Kriplani. Anuja Kriplani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Raab, Gabriel, Richard J. Wong, Eric J. Sherman, et al.. (2025). Clinical and surgical outcomes of neoadjuvant targeted therapy in anaplastic and differentiated thyroid cancer.. Journal of Clinical Oncology. 43(16_suppl).
4.
Desîlets, Antoine, David G. Pfister, Sarah Stein, et al.. (2024). A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer. Oral Oncology. 154. 106861–106861. 4 indexed citations
5.
Salz, Talya, Susan Chimonas, Anuja Kriplani, et al.. (2024). Pain Management for Post-Treatment Survivors of Complex Cancers: A Qualitative Study of Opioids and Cannabis. Pain Management. 14(2). 40–53. 1 indexed citations
6.
Salz, Talya, Patrick T. Bradshaw, Natalie Moryl, et al.. (2024). Role of primary care in opioid prescribing for older head and neck cancer survivors. Cancer. 130(22). 3913–3925.
7.
Wong, W. Douglas, Eric J. Sherman, Anuja Kriplani, et al.. (2024). 1931P Phase II study of PDR001 in combination with MAPK pathway inhibitors in patients with radioactive-refractory differentiated thyroid cancer (DTC). Annals of Oncology. 35. S1122–S1122. 1 indexed citations
8.
9.
Lipitz‐Snyderman, Allison, Susan Chimonas, Sham Mailankody, et al.. (2023). Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations. Cancer Medicine. 12(7). 8063–8072. 1 indexed citations
10.
Dunn, Lara, Eric J. Sherman, Alan L. Ho, et al.. (2023). LookUpTrials: Assessment of an artificial intelligence-powered mobile application to engage oncology providers in clinical trials.. JCO Global Oncology. 9(Supplement_1). 111–111. 1 indexed citations
11.
Kang, Jung Julie, Yao Yu, Linda Chen, et al.. (2022). Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer. CA A Cancer Journal for Clinicians. 73(2). 164–197. 39 indexed citations
12.
Salz, Talya, Jamie S. Ostroff, Chandylen L. Nightingale, et al.. (2021). The Head and Neck Survivorship Tool (HN-STAR) Trial (WF-1805CD): A protocol for a cluster-randomized, hybrid effectiveness-implementation, pragmatic trial to improve the follow-up care of head and neck cancer survivors. Contemporary Clinical Trials. 107. 106448–106448. 11 indexed citations
13.
Kriplani, Anuja, Jessica A. Lavery, Deborah Korenstein, et al.. (2020). Trends in chronic opioid therapy among survivors of head and neck cancer. Head & Neck. 43(1). 223–228. 12 indexed citations
14.
Burman, Bharat, Eric J. Sherman, Anuja Kriplani, et al.. (2020). Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers.. Journal of Clinical Oncology. 38(15_suppl). 6587–6587. 3 indexed citations
15.
Axelrad, Jordan E., Anuja Kriplani, Umut Özbek, et al.. (2016). Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease. Clinical Colorectal Cancer. 16(3). e205–e210. 14 indexed citations
16.
17.
Jobanputra, Vaidehi, Anuja Kriplani, V. P. Choudhry, & Kiran Kucheria. (1999). Detection of chromosomal abnormalities using fluorescence in situ hybridization (FISH).. PubMed. 11(6). 259–63. 4 indexed citations
18.
Kriplani, Anuja, et al.. (1996). Verrucous carcinoma of the vulva.. PubMed. 94(12). 456, 459–456, 459. 1 indexed citations
19.
Tandon, Ravi, et al.. (1992). Management of malignant germ cell tumours of ovary.. PubMed. 29(3). 122–5. 1 indexed citations
20.
Kabra, Madhulika, et al.. (1977). PRENATAL DIAGNOSIS OF DUCHENNE MUSCULAR DYSTROPHY. The Lancet. 310(8048). 1115–1116. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. J. Sanderson Breakdown of academic impact, for papers by Nobuya Monden Breakdown of academic impact, for papers by Bernard Lyons Breakdown of academic impact, for papers by Jamie A. Ku Breakdown of academic impact, for papers by Mateya Trinkaus Breakdown of academic impact, for papers by Aline Lauda Freitas Chaves Breakdown of academic impact, for papers by Laura M. Dooley Breakdown of academic impact, for papers by Caitlin McMullen Breakdown of academic impact, for papers by Jun Yong Breakdown of academic impact, for papers by Daniel Moualed
Rankless by CCL
2026